Small molecule melanin-concentrating hormone receptor 1 (MCH1R) antagonists as anxiolytic and antidepressive agents

被引：6

作者：

Dyck, B ^{[1
]}

机构：

[1] Neurocrine Biosci Inc, Dept Med Chem, San Diego, CA 92130 USA

来源：

DRUG DEVELOPMENT RESEARCH | 2005年 / 65卷 / 04期

关键词：

melanin-concentrating hormone; anxiety; depression;

D O I：

10.1002/ddr.20030

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The search for new anxiolytics and antidepressants with a more rapid onset of action has led researchers to pursue neuropeptide receptors as molecular targets for these indications. Among these peptide targets, melanin-concentrating hormone (MCH) has shown promising, albeit inconsistent, data supporting a role for this peptide in human emotional disorders. Neurochemical and neuroanatomical studies have revealed that MCH plays a key role in animal feeding and other behavior; however, alteration of MCH signaling by transgenesis or treatment with endogenous and synthetic MCH1R ligands has produced confounding results in animal models of human emotional disorders. This review describes recent contributions to the understanding of the role of MCH in animal stress response.

引用

页码：291 / 300

页数：10

共 91 条

[41] The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R). [J].

Kessler, RC ;

Berglund, P ;

Demler, O ;

Jin, R ;

Koretz, D ;

Merikangas, KR ;

Rush, AJ ;

Walters, EE ;

Wang, PS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (23) :3095-3105

[42] Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for obesity the treatment of obesity [J].

Kowalski, TJ ;

McBriar, MD .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (09) :1113-1122

[43] Distinct mechanism for antidepressant activity by blockade of central substance P receptors [J].

Kramer, MS ;

Cutler, N ;

Feighner, J ;

Shrivastava, R ;

Carman, J ;

Sramek, JJ ;

Reines, SA ;

Liu, GH ;

Snavely, D ;

Wyatt-Knowles, E ;

Hale, JJ ;

Mills, SG ;

MacCoss, M ;

Swain, CJ ;

Harrison, T ;

Hill, RG ;

Hefti, F ;

Scolnick, EM ;

Cascieri, MA ;

Chicchi, GG ;

Sadowski, S ;

Williams, AR ;

Hewson, L ;

Smith, D ;

Carlson, EJ ;

Hargreaves, RJ ;

Rupniak, NMJ .

SCIENCE, 1998, 281 (5383) :1640-1645

[44] SUBSTANCE-P IS INVOLVED IN THE SENSITIZATION OF THE ACOUSTIC STARTLE RESPONSE BY FOOTSHOCKS IN RATS [J].

KRASE, W ;

KOCH, M ;

SCHNITZLER, HU .

BEHAVIOURAL BRAIN RESEARCH, 1994, 63 (01) :81-88

[45] Antidepressant-like actions of an AMPA receptor potentiator (LY392098) [J].

Li, X ;

Tizzano, JP ;

Griffey, K ;

Clay, M ;

Lindstrom, T ;

Skolnick, P .

NEUROPHARMACOLOGY, 2001, 40 (08) :1028-1033

[46] The forced swimming test as a model for core and component behavioral effects of antidepressant drugs [J].

Lucki, I .

BEHAVIOURAL PHARMACOLOGY, 1997, 8 (6-7) :523-532

[47] Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism [J].

Marsh, DJ ;

Weingarth, DT ;

Novi, DE ;

Chen, HY ;

Trumbauer, ME ;

Chen, AS ;

Guan, XM ;

Jiang, MM ;

Feng, Y ;

Camacho, RE ;

Shen, Z ;

Frazier, EG ;

Yu, H ;

Metzger, JM ;

Kuca, SJ ;

Shearman, LP ;

Gopal-Truter, S ;

MacNeil, DJ ;

Strack, AM ;

MacIntyre, DE ;

Van der Ploeg, LHT ;

Qian, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :3240-3245

[48] New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants [J].

Martínez-Esparza, J ;

Oficialdegui, AM ;

Pérez-Silanes, S ;

Heras, B ;

Orús, L ;

Palop, JA ;

Lasheras, B ;

Roca, J ;

Mourelle, H ;

Bosch, A ;

Del Castillo, JC ;

Tordera, R ;

Del Río, J ;

Monge, A .

JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (03) :418-428

[49]

MARZABADI MR, 2004, Patent No. 6727264

[50]

MARZABADI MR, 2004, Patent No. 20040073036

← 1 2 3 4 5 6 7 8 9 10 →